Independent Factors Affecting Patient Compliance to Private Insurer-funded Health Case Management in Canada
By HealthForward |
Authors: Wendong Chen1, Yulia Krupitsky2, Bobby Currie3, Robert Lunny3, Andrea Baumgartner2, Kevin West2, Sandra Anderson1
- HealthForward’s health case management (HCM) program is designed to monitor health outcomes and manage drug costs of certain specialty medications covered by private insurance companies in Canada.
- Great-West Life (GWL) Assurance Company has been a part of HealthForward’s HCM program since 2012 to manage drug claim costs while maximizing patient compliance and health outcomes for its plan members using high cost specialty drugs in key specialty areas.
- This preliminary analysis explores the factors contributing to patient compliance to HCM and health outcomes within HealthForward’s HCM to provide insight into HCM impact on patient health and morbidity.
- To characterize patients with rheumatoid arthritis (RA) or Crohn’s disease (CD) who have been enrolled in HealthForward’s HCM program and covered by GWL for select specialty medications
- To explore the independent factors affecting patient compliance to HCM over a 6-month period in RA or CD patients insured by GWL and enrolled in HealthForward’s HCM program
- Patients participating in HealthForward’s HCM program had different disease and treatment characteristics that could impact HCM withdrawal risk.
- There was a significant reduction in HCM withdrawal risk for patients with less frequent treatment administration and longer duration of phone calls.
- This preliminary analysis sets the stage for future investigations within HCM programs and factors that could potentially maximize patient compliance and health outcomes.
1 Innomar Strategies Inc. Oakville, Canada; 2 HealthForward Inc. Oakville, Canada; 3 The Great-West Life Assurance Company, Winnipeg, Canada
Click below to download the full report, "Independent Factors Affecting Patient Compliance to Private Insurer-funded Health Case Management in Canada."